• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS ACCESS SOLUTION; CATHETER, SEPTOSTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS ACCESS SOLUTION; CATHETER, SEPTOSTOMY Back to Search Results
Lot Number VXF100823F
Medical Device Problem Code Material Frayed (1262)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/27/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event or Problem Description
It was reported that versacross access solution was selected for use during an atrial fibrillation (a fib) ablation.During the procedure, the sheath/dilator became bent/kinked/deformed, and it was noticed that the insulation material on the versacross rf wire at the proximal end was pulling away from the device and unraveling.No patient complications were reported.The procedure was completed successfully.The issue was noted upon opening the package.The device is expected to be returned for analysis.
 
Additional Manufacturer Narrative
The returned rf wire was analyzed.This is supplemental mdr to report investigation results (mdr aware date 30jan2024).Analysis of the device found that the insulation was damaged on the proximal end, and also it was kinked towards the center of the wire and the electrode was charred.The device passed inspection of wire body and proximal end other diameters.Also, the device passed electrode height inspection, and electrode/heat shrink gap inspections.The reported allegation was confirmed.
 
Event or Problem Description
It was reported that versacross access solution was selected for use during an atrial fibrillation (a fib) ablation.During the procedure, the sheath/dilator became bent/kinked/deformed, and it was noticed that the insulation material on the versacross rf wire at the proximal end was pulling away from the device and unraveling.No patient complications were reported.The procedure was completed successfully.The issue was noted upon opening the package.The device is expected to be returned for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS ACCESS SOLUTION
Common Device Name
CATHETER, SEPTOSTOMY
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BOSTON SCIENTIFIC DE COSTA RICA SRL
la lima business park
la lima, 03
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18352920
Report Number2124215-2023-69689
Device Sequence Number20530070
Product Code DXF
UDI-Device Identifier00685447011835
UDI-Public00685447011835
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K150709
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/19/2025
Device Lot NumberVXF100823F
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 12/04/2023
Supplement Date Received by Manufacturer01/30/2024
Initial Report FDA Received Date12/18/2023
Supplement Report FDA Received Date02/20/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/10/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Unknown
Patient Sequence Number1
Patient Age65 YR
Patient SexFemale
-
-